Well-known big three to start a rigorous review activities to thoroughly investigate the doctor's lecture fees.

Medicine Network September 15, according to medical recruitment news, recently, Wuhan, a three-a hospital launched a rigorous review activities, to count all doctors last year's clinical lecture fees.
it is understood that each doctor's account will be systematically transferred out for careful verification.
If you find out which fee is paid by which company on the doctor's account, the hospital disciplinary inspection committee will send a letter of assistance to the corresponding pharmaceutical company, requiring the company to provide, on a case-by-case basis, the invitation letter, teaching courseware, on-site photos, labor agreement, transfer card number, the amount involved, the schedule of the meeting and other relevant supporting materials.
addition, the supporting materials must be stamped with the corporate seal to prove the authenticity of the costs, and to be submitted to the hospital before the prescribed time limit.
, according to preliminary verification results, a doctor's account of funds involved dozens of well-known pharmaceutical companies.
doctor's account shows that many pharmaceutical companies in a few years, the cumulative number of calls in the hundreds, the largest one close to 600 times.
However, the above-mentioned hospitals also said that in the fight against illegal marketing, the hospital also allows in compliance, legal premise, the hospital and pharmaceutical enterprises to carry out exchanges, after which the hospital will establish and improve the exchanges and cooperation between the two sides before publicity, supervision in the event, after the record of the whole process management system.
, a hospital in Nanjing was also counting the doctor's lecture fees, asking the doctor to voluntarily report the lecture fees received.
analysis pointed out that if the relevant pharmaceutical companies to pay the lecture fees were found to be problematic, that the probability will also affect its follow-up in the hospital academic promotion.
National Health Care Commission to combat the use of academic conferences to carry out interest transmission analysis pointed out that the hospital for doctors' lecture fees verification may be in response to the National Health Care Commission's special action on medical anti-wind, this round of nationwide anti-wind will continue until the end of the year.
On June 5 this year, the National Health and Safety Commission, the Ministry of Public Security and other nine departments issued a "2020 correction of the field of pharmaceutical purchase and sale and medical services in the wrong wind work points" document stressed that serious investigation and punishment of the collection of pharmaceutical supplies enterprises rebate behavior.
According to the simultaneous release of the "2020 correction of the field of pharmaceutical purchase and sale and medical services in the field of special governance of the key tasks of the division of tasks": before the end of the year, led by the National Health and Health Commission, member units in accordance with the division of responsibilities to cooperate, regulate the way of cooperation and exchanges between medical and commercial.
the bottom line of behavior between trade associations, medical institutions and pharmaceutical-related enterprises, and formulate norms for medical personnel's conduct in foreign exchanges.
crack down on misconduct by using academic conferences, scientific collaboration, academic support, and donations to channel benefits.
division of labor table also requires that, before the end of the year, led by the National Health and Health Commission, member units in accordance with the division of responsibilities to cooperate, regulate the way of cooperation and exchanges between medical and commercial.
the bottom line of behavior between trade associations, medical institutions and pharmaceutical-related enterprises, and formulate norms for medical personnel's conduct in foreign exchanges.
, which is different from the verification of kickbacks, charges and commercial bribery in medicine for some time, this time the hospital focused its verification on the doctor's lecture fees.
Lecture fees are part of the promotion of pharmaceutical companies on the issue of lecture fees, Beijing Sheng Shikang to Chinese medicine marketing planning company chairman Shen Yong said today, in general, lecture fees themselves are part of the academic promotion costs, but also reasonable.
he understood that doctors in some hospitals were themselves professors at medical universities, and that teaching was part of their work, in addition to routine consultations.
pharmaceutical companies often invite experts to lecture through some medical platforms, associations, etc.
, generally speaking, including the popularization of health education, publicity of common diseases related knowledge, improve patient awareness of diseases and other content.
academic conferences have a positive effect on doctors' understanding of medicines, patients' understanding of diseases, and the popularization of health knowledge.
in Europe and the United States, lecture fees are long-term and widespread, but also basically recognized as legal and reasonable costs.
But it must also be noted that this does not mean that the invitation of doctors to lectures, as well as the payment of lecture fees are compliant, there are some pharmaceutical companies in the transfer of lecture fees as a "shame cloth" for the benefit of the transport.
addition, different hospitals have different management practices for doctors' lecture activities, and in this hospital compliance lecture behavior, in another hospital may not necessarily be compliant.
Shenyong told Seberan that some hospitals charge doctors for lectures, but also some of the hospital's management fees.
analysis points out that, in general, pharmaceutical companies for individual customers of the number of lectures and the number of fee payments are capped, generally several times a month, dozens of times a year within a reasonable range.
addition to the number of visits, some of the supporting information confirming whether the meeting erred was relevant is also an important evidence of compliance in determining the issuance of lecture fees.
in the real medicine marketing, there are doctors did not go to lectures, but pharmaceutical companies to pay the form of lecture fees for the transfer of benefits.
documents include the above-mentioned invitation letter, courseware, on-site photos, labor agreement, transfer card number, amount involved, meeting itinerary, etc.
, Shen Yong also pointed out that the payment of lecture fees whether or not to pay taxes is also an important measure of the legality of the fees.
Finally, for the governance of lecture fees, Shen Yong said that also need to grasp the scale, because if the management is too strict, doctors do not go to lecture, but also not conducive to the dissemination of medical information, medicine is a very practical discipline, the layer of subject knowledge dissemination is necessary.
recent period, around the cost of the issue, pharmaceutical companies require pharmaceutical representatives to advance large amounts of capital, a number of pharmaceutical companies to reduce costs of the news continues to come out.
now under the strict inspection of medical correction, lecture fees have become the focus of hospital verification.
have to say that under the pressure of policies such as volume procurement, tax verification and medical correction, the traditional marketing model of pharmaceutical companies is facing a severe impact.
the medical representatives who are in it, there is still a need to strengthen their ability to conduct academic outreach and increase compliance and safety awareness.
.